$47.85 $0.56 (0.0%)

04:00 PM EDT on 07/29/19

Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Current Price $47.85 Mkt Cap $5.0B
Open $47.96 P/E Ratio 0.00
Prev. Close $47.85 Div. (Yield) $0.00 (0.0%)
Daily Range $47.85 - $47.98 Volume 8,122,280
52-Wk Range $13.81 - $47.98 Avg. Daily Vol.

Caps

How do you think NASDAQ:ARRY will perform against the market?

Add Stock to CAPS Watchlist

All Players

259 Outperform
19 Underperform
 

All-Star Players

51 Outperform
6 Underperform
 

Wall Street

10 Outperform
1 Underperform
 

Top NASDAQ:ARRY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bichon2 (< 20)
Submitted March 06, 2013

Great drug to treat braf mutation cancers. Also good results in multiple myeloma .

zzlangerhans (99.81)
Submitted April 25, 2012

It's rather dangerous to red thumb a beaten down cancer or hepatitis biotech, because each one has a finite possibility of rising from the ashes like a Phoenix (or a Pharmasset or Pharmacyclics). Once the market anoints a developmental drug as the… More

NASDAQ:ARRY VS S&P 500 (SPY)

Fools bullish on NASDAQ:ARRY are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ARRY.

Recs

0
Member Avatar TMFang4apples (50.59) Submitted: 1/8/2019 6:58:41 PM : Outperform Start Price: $17.55 NASDAQ:ARRY Score: +156.51

Braftovi plus Mektovi are probably worth 3.7 billion on their own, which makes this a fairly safe bet. With Lilly promoting the drugs Loxo bought from Array, there's a lot of potential upside too.

Recs

0
Member Avatar Aiming (< 20) Submitted: 8/21/2015 8:49:14 AM : Outperform Start Price: $5.15 NASDAQ:ARRY Score: +780.84

Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year

Recs

0
Member Avatar NuclearSteve (62.38) Submitted: 5/17/2015 10:59:22 PM : Outperform Start Price: $7.24 NASDAQ:ARRY Score: +519.97

Comparing Baker Bro moves from cur qtr to last qtr - looking at 13F-HR. The upped their stake in ARRY by 300%

Leaderboard

Find the members with the highest scoring picks in ARRY.

Score Leader

UncleSachse

UncleSachse (< 20) Score: +2,015.14

The Score Leader is the player with the highest score across all their picks in ARRY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
UncleSachse < 20 10/21/2009 Outperform 1Y $2.09 +2,189.47% +174.33% +2,015.14 0 Comment
EvilUnicorn 67.15 11/17/2009 Outperform 5Y $2.21 +2,070.07% +169.71% +1,900.36 0 Comment
wes29 65.42 6/10/2011 Outperform 3M $2.40 +1,893.75% +132.15% +1,761.60 0 Comment
AlpineFirst < 20 3/23/2010 Outperform 3Y $2.47 +1,837.25% +156.06% +1,681.19 0 Comment
ChronicInvestor 30.79 10/2/2009 Outperform 3Y $2.45 +1,853.06% +193.22% +1,659.84 0 Comment
stmbpsak 82.94 10/13/2009 Outperform 3Y $2.47 +1,837.25% +178.44% +1,658.81 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. 21popsontop 45.28 1/28/2010 Outperform 3Y $2.51 +1,806.37% +173.93% +1,632.45 1 Comment
robbg52999 80.59 10/12/2009 Outperform NS $2.51 +1,806.37% +177.79% +1,628.58 0 Comment
lola99999 < 20 12/17/2009 Outperform 1Y $2.57 +1,761.87% +170.17% +1,591.70 1 Comment
boardwalken65 31.87 2/10/2012 Outperform 3M $2.65 +1,705.66% +123.01% +1,582.65 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.29 1/29/2015 Underperform 3W $7.46 +541.42% +48.09% -493.33 0 Comment
TrackCantorFitz 42.20 5/30/2014 Outperform NS $4.36 +997.48% +55.64% +941.83 0 Comment
TrackJimCramer 86.29 9/27/2013 Outperform 3W $6.10 +22.30% +19.58% +2.71 1/29/2015 @ $7.46 0 Comment
TrackUBS 89.72 7/23/2010 Outperform NS $3.16 +1,414.24% +172.63% +1,241.61 0 Comment
TrackUBS 89.72 11/10/2009 Outperform NS $2.03 +84.24% +10.56% +73.68 4/22/2010 @ $3.74 0 Comment
TrackWMBlair 73.84 2/7/2008 Outperform NS $5.66 +745.41% +135.14% +610.27 0 Comment
TrackMorganJos 65.10 12/4/2007 Outperform NS $11.40 +319.74% +113.69% +206.05 0 Comment
TrackCollinsStew 69.90 11/7/2007 Outperform NS $9.95 +380.90% +108.32% +272.59 0 Comment
TrackLehmanBros < 20 10/9/2007 Outperform NS $10.90 -68.17% -11.27% -56.90 4/17/2012 @ $3.47 0 Comment
TrackEveillard 92.59 9/30/2007 Outperform NS $11.23 +326.09% +105.40% +220.69 1 Comment
TrackRodmanRen < 20 8/13/2007 Outperform NS $11.06 +332.64% +114.94% +217.70 0 Comment
TrackJPMorgan 86.91 5/23/2007 Outperform NS $13.01 -71.56% -22.32% -49.24 4/30/2010 @ $3.70 0 Comment
TrackPiperJaff 84.71 1/4/2007 Outperform NS $12.57 +280.67% +124.81% +155.86 0 Comment
TrackOppenheimer < 20 12/15/2006 Outperform NS $13.02 +267.51% +122.27% +145.24 0 Comment
TrackUnterberg < 20 12/7/2006 Outperform NS $13.20 -77.50% -7.96% -69.54 6/24/2008 @ $2.97 0 Comment
TrackWRHambrecht < 20 11/9/2006 Outperform NS $11.92 -70.89% -0.69% -70.20 4/17/2012 @ $3.47 0 Comment
TrackBofASec 91.68 11/2/2006 Outperform NS $9.60 +398.44% +130.83% +267.60 0 Comment
TrackRWBaird 89.58 10/26/2006 Outperform NS $9.52 -69.85% -27.03% -42.82 9/4/2009 @ $2.87 0 Comment